ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Opus Genetics Inc

Opus Genetics Inc (IRD)

4.07
0.01
(0.25%)
終了 6月22日 5:00AM
4.10
0.03
(0.74%)
取引時間後: 8:00AM

Opus Genetics Inc (IRD) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
4.10
( 0.99% )
買値
3.86
売値
4.10
出来高
1,056,630
4.035 日の範囲 4.26
0.9011 52 週間の範囲 5.81
時価総額
前日終値
4.06
始値
4.17
最終取引時間
財務取引量
US$ 4,323,201
VWAP
4.0915
平均取引量 (3 か月)
US$ 819,438
発行済株式数
81,395,539
配当利回り
PER
-2.85
1 株当たり利益 (EPS)
-1.42
歳入
11.98M
純利益
-106.93M

Opus Genetics Inc について

Opus Genetics, Inc., a clinical-stage biopharmaceutical company, develops gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs) and other types of therapies for additional ophthalmic disorders. It develops OPGx-LCA5, an early-onset retinal degenera... Opus Genetics, Inc., a clinical-stage biopharmaceutical company, develops gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs) and other types of therapies for additional ophthalmic disorders. It develops OPGx-LCA5, an early-onset retinal degeneration that is in Phase 1/2 clinical trial for the treatment of LCA5-associated IRD; and OPGx-BEST1 to treat BEST1-associated retinal disease. The company also develops various pre-clinical IRD programs, including OPGx-RHO, a gene therapy that targets autosomal dominant retinitis pigmentosa caused by RHO mutations; OPGx-RDH12 that is designed to restore protein expression and halt functional deterioration in patients with retinal dystrophy caused by mutations in the retinal dehydrogenase gene; OPGx-MERTK, an AAV vector for the treatment of MERTK IRD; OPGx-NMNAT1, a gene augmentation therapy designed to halt functional deterioration in pediatric patients with retinal degenerative disease caused by mutations in the nicotinamide mononucleotide adenylyltransferase 1 gene; and OPGx-CNGB1, an AAV gene therapy for retinitis pigmentosa due to mutations in the CNGB1 gene. In addition, it develops Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as for the treatment of presbyopia and dim light or night vision disturbances and APX3330, a small-molecule inhibitor of Ref-1 for the treatment of diabetic retinopathy. Opus Genetics, Inc. was formerly known as Ocuphire Pharma, Inc. and changed its name to Opus Genetics, Inc. in November 2020. The company was founded in 2018 and is headquartered in Durham, North Carolina. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Durham, United States
設立
2026
Opus Genetics Inc is listed in the Healthcare sector of the ナスダック市場 with ticker IRD. The last closing price for Opus Genetics was US$4.06. Over the last year, Opus Genetics shares have traded in a share price range of US$ 0.9011 to US$ 5.81.

Opus Genetics currently has 81,395,539 shares in issue. The market capitalisation of Opus Genetics is US$333.72 million. Opus Genetics has a price to earnings ratio (PE ratio) of -2.85.

IRD 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.25.128205128213.94.253.87437003.97589312CS
4-0.44-9.691629955954.544.6753.88107984.12527601CS
12-0.6-12.76595744684.75.813.88186064.75389167CS
262.08102.970297032.025.811.888438234.079438CS
523.16336.1702127660.945.810.90116464003.21451397CS
1562.91244.5378151261.195.810.655791802.52108413CS
2602.91244.5378151261.195.810.655791802.52108413CS

IRD - Frequently Asked Questions (FAQ)

What is the current Opus Genetics Inc share price?
The current share price of Opus Genetics Inc is US$ 4.10
How many Opus Genetics Inc shares are in issue?
Opus Genetics Inc has 81,395,539 shares in issue
What is the market cap of Opus Genetics Inc?
The market capitalisation of Opus Genetics Inc is USD 333.72M
What is the 1 year trading range for Opus Genetics Inc share price?
Opus Genetics Inc has traded in the range of US$ 0.9011 to US$ 5.81 during the past year
What is the PE ratio of Opus Genetics Inc?
The price to earnings ratio of Opus Genetics Inc is -2.85
What is the cash to sales ratio of Opus Genetics Inc?
The cash to sales ratio of Opus Genetics Inc is 27.44
What is the registered address of Opus Genetics Inc?
The registered address for Opus Genetics Inc is 8 Davis Drive, Durham, North Carolina, 27713
What is the Opus Genetics Inc website address?
The website address for Opus Genetics Inc is opusgtx.com
Which industry sector does Opus Genetics Inc operate in?
Opus Genetics Inc operates in the Biotechnology & Life Sciences sector

IRD 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock